IBM and Hangzhou CognitiveCare signed an agreement to introduce Watson for Oncology to hospitals across China. This is Watson Health’s first partnership in China.
21 hospitals across China plan to adopt Watson for Oncology trained by Memorial Sloan Kettering, a cognitive computing platform for physicians.
Hangzhou CognitiveCare, set up to bring cognitive computing in China, will provide sales, service and customer support including localization of Watson’s insights for doctors in China.
Watsonfor Oncology will initially be available in the English language only. CognitiveCare will provide some translation support to ensure Watson’s treatment insights – such as drug labels and treatment guidelines – are available to customers in appropriate Chinese dialects. CognitiveCare will localize dosing based on Chinese medical guidelines.
To advance the adoption of Watson for Oncology in the region, Hangzhou CognitiveCare will build on its regional network of teleconsultation system service providers tapping into their knowledge of the region, the medical community, and the health needs of the population.
Watsonfor Oncology was developed by IBM in collaboration with Memorial Sloan Kettering Cancer Center, one of the world’s leading cancer centers.
Watson for Oncology draws from a corpus of information, including more than 300 medical journals, more than 200 textbooks, and nearly 15 million pages of text to provide recommendations about different drug options and administration instructions.